Podcasts about screenings

This week in the Screening Room, Zeth's talking about Sam Raimi and the directors who returned to their indie/DIY/genre roots after doing time in the Hollywood system. Also: movies about curses, 21st century horror films, and a mixtape inspired by Raimi's 2009 film ‘Drag Me to Hell.' To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Send a textBen and Daphna conclude Journal Club with a quality improvement study from Pediatrics titled "Improving Health-Related Social Needs Screening and Support Across a Pediatric Health Care System". The hosts discuss the successful implementation of universal social determinants of health (SDOH) screening across nine pediatric divisions at Levine Children's. They highlight the impressive results—screening compliance reaching 92%—and the practical impact of connecting families to resources like FindHelp.org, which led to a 56% resolution rate in food insecurity for positive screens. Daphna makes a personal commitment to improve resource accessibility in her own unit.----Improving Health-Related Social Needs Screening and Support Across a Pediatric Health Care System. Laroia R, Minor W, Carr A, Buitrago Mogollon T, White BB, Mabus S, Stilwell L, Ahmed A, Mehta S, Obita T, Reed S, Senturias Y, Mittal S, Horstmann S, Demmer L, Dantuluri K, Chadha A, Noonan L, Courtlandt C.Pediatrics. 2026 Feb 5:e2024070035. doi: 10.1542/peds.2024-070035. Online ahead of print.PMID: 41638605Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

When Donald Trump returned to office, he pledged the largest immigration crackdown in U.S. history. While public debate centered on mass deportations, a quieter — and potentially more consequential — transformation has taken shape: the rapid expansion of immigrant detention capacity inside the United States. New 2025 data shows that 77% of people newly placed into deportation proceedings had no criminal conviction. At the same time, ICE is consolidating more than 200 detention sites into 34 massive facilities — including proposed “mega-centers” capable of holding up to 10,000 people each. Planned sites span Georgia, Maryland, Texas, and Arizona, with total capacity projected to approach 100,000 beds. A controversial Department of Homeland Security memo now directs mandatory “re-vetting” of refugees at the one-year mark, allowing detention during inspection with no defined time limit. Critics argue this creates the risk of prolonged — even indefinite — confinement for people lawfully admitted to the United States. Federal judges have rebuked elements of the policy, citing constitutional concerns and unlawful detention practices. Meanwhile, fatal encounters involving federal immigration officers and a wave of collapsed federal prosecutions have intensified scrutiny. Supporters call the overhaul modernization and a restoration of order. Opponents see the construction of a permanent detention infrastructure that could outlast any single administration. Independent media has never been more important. Please support this channel by subscribing here: https://www.youtube.com/channel/UCkbwLFZhawBqK2b9gW08z3g?sub_confirmation=1 Join this channel with a membership for exclusive early access and bonus content: https://www.youtube.com/channel/UCkbwLFZhawBqK2b9gW08z3g/join Five Minute News is an Evergreen Podcast, covering politics, inequality, health and climate - delivering independent, unbiased and essential news for the US and across the world. Visit us online at http://www.fiveminute.news Follow us on Bluesky https://bsky.app/profile/fiveminutenews.bsky.social Follow us on Instagram http://instagram.com/fiveminnews Support us on Patreon http://www.patreon.com/fiveminutenews You can subscribe to Five Minute News with your preferred podcast app, ask your smart speaker, or enable Five Minute News as your Amazon Alexa Flash Briefing skill. CONTENT DISCLAIMER The views and opinions expressed on this channel are those of the guests and authors and do not necessarily reflect the official policy or position of Anthony Davis or Five Minute News LLC. Any content provided by our hosts, guests or authors are of their opinion and are not intended to malign any religion, ethnic group, club, organization, company, individual or anyone or anything, in line with the First Amendment right to free and protected speech. Learn more about your ad choices. Visit megaphone.fm/adchoices

  In this episode, Freddie and Renee zoom out on the modern wellness landscape—where tech, supplements, scans, and strong opinions are everywhere—and make a case for discernment over dogma. They talk candidly about online criticism, influencer skepticism, and why “trying things” only works when you introduce tools one at a time, track outcomes (HRV, sleep, glucose), and don't confuse information with wisdom. The through-line is simple: foundational health still matters, but intelligent experimentation can be powerful when it's paired with humility and real feedback loops. Then the conversation goes deep into two high-stakes areas people rarely discuss honestly: full-body MRI screening and biological dentistry. Renee shares her Prunuvo experience—how a possible kidney finding triggered weeks of stress and a cascade of follow-up imaging and specialist visits, raising the hard question of where early detection ends and false positives begin. From there, she opens up about a long dental arc that started with a traumatic accident at 16, eventually leading her to remove older titanium implants, manage bone loss and grafting, and transition to zirconia ceramic implants—not as fear-based medicine, but as a “reduce the burden” choice while she explores chronic fatigue, immune markers, and Episode Highlights [00:00] – Renee's Pranuvo full-body MRI experience and the 15mm kidney stone scare [16:02] – False positives, medical rabbit holes, and the emotional/financial cost of early detection [22:53] – Top health yardsticks: glucose markers, HRV, sleep tracking, and foundational labs [25:08] – CGMs, cortisol testing (Dutch & ELi Health), and why trends matter more than single data points [27:15] – Genetic testing, APOE4 status, and using DNA as a focus tool (DNA Company & SelfDecode) [51:37] – Renee's dental trauma story: accident, titanium implants, and root canal decisions [54:56] – Titanium implants, ANA positivity, chronic fatigue, and biocompatibility concerns [59:22] – Surgery recovery protocol: red light therapy, StemRegen, BPC-157 & TB-500 peptides [01:29:10] – Closing reflections and exosome therapy mention   Links & Resources Learn more about Renee Belz → https://reneebelz.com/ Follow Renee on Instagram → https://www.instagram.com/reneebelz/ Listen to the Biohacker Babes: https://podcasts.apple.com/us/podcast/renee-belz-lauren-sambataro/id1470189843 Get Silver Biotics: bit.ly/3JnxyDD — 30% off with Code: BEAUTIFULLYBROKEN Try CatchBio: https://catchbio.com — Code: BEAUTIFULLYBROKEN LightPathLED: https://lightpathled.pxf.io/c/3438432/2059835/25794 — Code: beautifullybroken StemRegen: stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52 — Code: beautifullybroken   CONNECT WITH FREDDIEWork with Me: https://www.beautifullybroken.world/biological-blueprintWebsite and Store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/freddie.kimmelYouTube: https://www.youtube.com/@beautifullybrokenworld Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this Dear Damona episode, we tackle what to do when someone keeps canceling last minute before you've even had a first date, and how to tell the difference between giving someone a fair chance and letting them waste your time. This week, a listener named Jenna shares: "I matched with a guy on a dating app and followed your advice. After a week of messaging, I asked him for a brief phone call. He was so fun to talk to, and we seemed aligned. We agreed to meet for drinks after work. The day of the date came, and at lunchtime he texted and apologized that a work emergency came up and he had to cancel. He asked to reschedule and we found a day the following week, and he canceled again with a similar work situation." What You'll Hear In This Episode: Why that gut feeling of resistance before rescheduling is actually your bodily wisdom talking The real difference between the benefit of the doubt and gullibility The must-do screening steps that reduce ghosting and flakiness What two last-minute cancels actually reveal about someone's priorities The hidden cost of rescheduling for someone who keeps flaking Resources & Links: Unlock the secret to successful dating with our Date Tracker at ⁠Damonahoffman.com/datetracker ⁠ Call or text your question to: 424-246-6255. Follow @DamonaHoffman on ⁠Instagram⁠, ⁠TikTok⁠, or ⁠Facebook⁠ and submit questions via DM or voice memo anytime. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Nancy Beran, MD, Vice President and Chief Quality Officer of ambulatory care at Northwell Health, shares how her team screened more than 700,000 patients for depression, redesigned ambulatory quality oversight across 1,000 sites, and is leading integration and Epic implementation to drive safer, more standardized care.

Send us a message!In this episode we will be covering Facebook Live Questions 2/10-2/24/26  from Dana's free Facebook Group Registered Dietitian Exam Study Group with Dana RD!Check out the Practice Questions Program here.  Grab the Acronym flashcards here.Get the free RD Exam Prep Masterclass here. test out the recorded classes with the Free Trial.  Looking for additional tutoring service? Visit my website! Shop all recorded courses at https://danajfryernutritiontutoring.teachable.comJoin the RD Exam Prep Mastery Program for access to the Situational Practice Questions,  Key Topics Review, Vocab Classes, Wed 8pest Group tutoring , study guides and a new trouble area video each week!Need a Crash Course before your exam? Check out the 4 part Pre-Exam Crash Course: Key Topics Review.

My guests this week are Professor Paul Lacaze and Jane Tiller - two leading voices shaping the future of public health genetics in Australia. Professor Lacaze is a Professor of Genetics and part of the team behind DNA Screen, a major initiative exploring how preventive DNA testing could help identify people at high genetic risk of cancer and heart disease while they're still young and healthy. Jane Tiller is a lawyer and genetic counsellor with deep expertise in the policy and ethical frameworks needed to make genomic screening safe, trusted, and accessible at scale. Best known for their work on the DNA Screen pilot study, Paul and Jane are helping drive a shift from reactive healthcare, where genetic testing often happens after disease appears to anticipatory healthcare that uses genetics as a preventive screening tool, alongside existing public health programs like mammograms and bowel cancer screening. In this episode of Humans of Purpose, we explore what preventive DNA screening could mean for Australia, including: what the DNA Screen pilot found (including the number of young adults carrying high-risk, actionable genetic variants) why early screening gives people time to make informed decisions about surveillance, prevention, and family planning what “actionable” genes really means (and why lifestyle changes alone can't remove certain risks the importance of protecting Australians from genetic discrimination and why data governance, privacy, transparency and participant choice are essential if a program like this is to earn public trust. Tune in to hear how Paul and Jane are working to mainstream genomic risk management into the health system and what it could take to move from pilot to national scale.

Today we'll be talking about new airport screening policies rolling out imminently, how Thailand ranks amid global taxi scam complaints, and a little later a foreign travelers viral complaints about rude treatment in Thailand has elicited strong reactions online.

Episode summaryThis week on The Franchise Advisory Board Podcast, Dave Hansen sits down with Dr. Alan Lasky, SVP at Reliable Background Screening (and former almost-songwriter-for-the-Jacksons… casually) to tackle a topic that's getting way more complicated: how to reduce hiring risk in the age of AI, deepfakes, and “resume inflation.”Big thanks to ClientTether, our episode sponsor, for helping franchise brands automate and standardize the processes that keep operators consistent, compliant, and sane.Episode highlightsAI in hiring: embrace it… but don't outsource your judgmentAlan's clear: this isn't an anti-AI episode. AI belongs in modern hiring—but it has to be used responsibly. The core risk? Bias and compliance exposure can sneak in when AI tools are unmonitored, unmeasured, or used without clear guardrails.Key safeguards discussed:Keep a human review in the loop before AI outputs influence decisionsBe transparent with candidates that AI is being used (even “AI note-takers”)Build internal policies and training so interviewers know what to watch forThe new threat: deepfakes and fake candidatesThe numbers are trending in a scary direction:Gartner projection: by 2028, 1 in 4 job applicants could be fakeReports cited from SHRM/Forbes: 70% of candidates misrepresent themselves, with “resume inflation” accelerating via AI toolsReliable (and the broader screening industry) is responding with identity verification approaches that combine:ID upload + guided selfie video (blink/turn prompts)biometric matching to confirm the candidate is real and consistentbehind-the-scenes handling designed to stay sensitive to EEOC/ADA concernsHiring best practices that actually hold upA few practical “do-this-now” moves that came up repeatedly:Compare resume vs LinkedIn vs interview story for consistencyUse skills assessments, ideally proctored or monitored when remoteSet explicit candidate guidelines for AI use (what's allowed vs not)Train interviewers to spot red flags like inconsistencies, delays, and mismatchUse social media checks carefully—ideally filtered through a screening partner to avoid pulling in protected-class infoCompliance is getting messier: states and citiesAI regulations are already active in places like Colorado, California, Illinois, New Jersey, and New York City, and Alan notes 20+ bills are moving through the pipeline. The theme across these rules:don't discriminatedocument your policykeep a human elementdisclose AI usageOn top of that, municipal laws are adding another layer (example discussed: shifting lookback windows in certain cities), making “multi-state + multi-unit + remote hiring” a true complexity party.Adverse action: the “right to dispute” mattersWhen a background check surfaces something negative, employers need to follow adverse action practices and give candidates the chance to dispute inaccuracies—because false positives happen (aliases, shared names, court data errors, etc.). Some states are now requiring more specific disclosure about why a decision was made and how it relates to the job.Franchisors, franchisees, and joint employer riskFor brands wanting to share hiring best practices systemwide: yes, you can educate—but do it smart.Keep it informationalAdd “consult legal counsel” languageBe careful not to cross lines that create joint-employer exposureThe vibe-check takeawayAI is speeding up hiring—but it's also speeding up fraud, mistakes, and legal risk. The winning play isn't “avoid AI.” It's standardize the process, document your policy, verify identity, and keep humans accountable for final decisions.

Incarcerated men defy the odds to expose a cover-up. In 2019, filmmakers visit an Alabama prison to film a revival meeting. Off camera, incarcerated men whisper a message: terrible things are going on here that are being kept secret from the public. This sparks an immersive 6-year investigation to discover the reality behind the walls of what the film calls “the nation's deadliest prison system.”With unprecedented direct access, the filmmakers learn from incarcerated men about a suspicious and violent death. The story unfolds in real time, revealing it isn't an isolated incident, and that the official version appears far from the truth. What follows is a shocking story of brutality, corruption, and a system in collapse. As the men fight for their own survival, they embark on a campaign of resistance, against all odds.Join us for a screening of the Oscar-nominated new documentary Alabama Solution, followed by a Q&A with director and producer Andrew Jarecki  This program contains EXPLICIT language. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Nancy Beran, MD, Vice President and Chief Quality Officer of ambulatory care at Northwell Health, shares how her team screened more than 700,000 patients for depression, redesigned ambulatory quality oversight across 1,000 sites, and is leading integration and Epic implementation to drive safer, more standardized care.

The ACOG states that, “Iron deficiency anemia during pregnancy has been associated with an increased risk of low birth weight, preterm delivery, and perinatal mortality and should be treated with iron supplementation in addition to prenatal vitamins. In addition, there may be an association between maternal iron deficiency anemia and postpartum depression, with poor results in mental and psychomotor performance testing in offspring”. Screening for anemia is included in most prenatal lab sets. However, up to 42% of women who enter prenatal care are iron deficient BEFORE anemia is detected. Iron deficiency itself, even without anemia, has also been linked to pregnancy morbidity. The ACOG currently does not have a statement endorsing universal ferritin screening in pregnancy outside of established anemia, but new data is challenging this (Jan 2026, Lancet). Listen in for details. 1. ACOG PB 2332. Wasim T, Bushra N, Nasrin T, Humayun S, Tajammul A, Khawaja KI, Irshad S, Fatima S, Yasin A, Zamora J, Cano-Ibáñez N, Fernandez-Felix BM, Khan KS; Ferritin screening and iron treatment for maternal anaemia and fetal growth restriction prevention (FAIR) Study Group. Intravenous iron for non-anaemic iron deficiency in pregnancy: a multicentre, two-arm, randomised controlled trial. Lancet Haematol. 2026 Jan;13(1):e22-e29. doi: 10.1016/S2352-3026(25)00315-1. PMID: 41482443.3. https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.15196

This week in the Screening Room, Zeth's got the sins of the father on his mind – as well as Christopher Walken's incredible mustache. Take a trip back to 1986 as we look at one of the most underrated films in Walken and Sean Penn's filmographies. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Today, I'm joined by the trailblazing Dr. Regina Druz, a cardiologist who reimagined heart health after years in elite academic medicine. In this episode, Dr. Druz opens up about her journey from the traditional halls of Cornell and New York Presbyterian to creating truly personalized, preventive, and holistic programs for her patients—even when it meant leaving behind the medical mainstream.   Episode Timestamps: Podcast intro and Dr. Druz's background ... 00:00:00 The value of female perspectives in cardiology ... 00:04:11 Moving from traditional to integrative cardiology ... 00:13:17 Upsides of personalization vs. "fire and forget" ... 00:22:15 Prevention through personalized genetics ... 00:26:11 Population vs. individual risk and aging ... 00:38:05 Impact of genetics and nutrition on heart health ... 00:45:07 Healthcare's prevention gap ... 00:48:38 Deeper causes: treating the "why," not just blocked arteries ... 00:50:18 Screening earlier and understanding vascular age ... 01:05:30 Epicardial fat, inflammation, and menopause's impact ... 01:10:39 Wearables, AI, and the future of cardiology ... 01:22:18 Heart-brain connection: stress, trauma, and longevity ... 01:26:35   Our Amazing Sponsors: Cozy Earth – Thoughtfully designed bedding and bath essentials that turn your home into a calm, elevated retreat and actually hold up wash after wash. Give your space a reset at cozyearth.com with code LONGEVITY for up to 20% off, and don't forget to mention this podcast in the post-purchase survey.   Magnesium Breakthrough by BIOptimizers — A full-spectrum magnesium supplement combining seven highly absorbable forms to support sleep, stress, muscle recovery, and nervous system balance in one nightly habit. Save 15% at bioptimizers.com/bionat with code BIONAT Complete Liver Complex by LVLUP Health - supports your liver's natural detox pathways so your body can reset after the holidays without suffering. Go  to lvluphealth.com and use code NAT for 20% off.   Nat's Links:  YouTube Channel Join My Membership Community Sign up for My Newsletter  Instagram  Dr. Bill Lawrence Episode

Episode 213: HIV PrEP Review H. Nicole Magaña, medical student, reviews the history of PrEP and outlines the currently FDA-approved medications used for HIV prevention. Dr. Arreaza provides additional perspective on long-acting injectable options, including how quickly they begin to protect patients after initiation.   Written by Nicole Magana, MSIV, American University of the Caribbean. Comments and edits by Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice. Pre-exposure prophylaxis for HIV. Previous episodes related to HIV:  -Episode 67, HIV history (September 2021) -Episode 68, HIV transmissibility (October 2021) -Episode 70 (October 2021), HIV prevention (including HIV Prep with oral medications) -Episode 98 (June 2022), we introduced Apretude, the first injectable for HIV PrEP. Apretude was approved in December 2021.  What is Pre-Exposure prophylaxis (PrEP)? Pre-exposure prophylaxis, or PrEP, is the use of antiretroviral medications taken by individuals who are HIV-negative to prevent HIV acquisition. There are 30,000 new HIV infections annually in the US.  How effective is it? When taken as prescribed, PrEP is highly effective at reducing the risk of HIV transmission through sexual exposure and injection drug use. Patients who are adherent to PrEP can lower their risk of contracting HIV by 99%. The effectiveness of oral PrEP is highly adherence dependent. In trials with 70% adherence, the relative risk of HIV acquisition was 0.27, compared to 0.51 with 40-70% adherence and no significant benefit with adherence ≤40%. How does PrEP work? PrEP works by maintaining therapeutic drug levels in the bloodstream and in target tissues. If HIV exposure occurs, viral replication is inhibited, preventing the establishment of infection. Brief History of PrEP. The concept of PrEP originated from early animal studies demonstrating that antiretroviral medications could prevent retroviral transmission when administered before exposure. In 2010, the iPrEx trial showed that daily oral tenofovir disoproxil fumarate (known as Truvada) with emtricitabine significantly reduced HIV acquisition among men who have sex with men and transgender women. This was the first large clinical trial to demonstrate the effectiveness of PrEP. In 2012, the FDA approved oral Truvada, which is TDF/FTC (tenofovir disoproxil and emtricitabine) for HIV prevention. Since then, additional studies have expanded indications and introduced new formulations, including long-acting injectable options. Who Should Be Offered PrEP? PrEP should be considered for any HIV-negative individual at increased risk of HIV acquisition, including Men who have sex with men, transgender individuals, heterosexual men and women with an HIV-positive partner, individuals with recent bacterial sexually transmitted infections, people who inject drugs, individuals engaging in condomless sex with partners of unknown HIV status. Remember that PrEP should be offered in a nonjudgmental, patient-centered manner, make it a safe space to talk openly about prevention of HIV.  Available HIV PrEP Options. Daily Oral PrEP: There are 2 formulations of Tenofovir. There is Tenofovir disoproxil fumarate (TDF)/ Truvada and Tenofovir alafenamide (TAF)/ Descovy. Each is available in a tablet combined with Emtricitabine a nucleoside reverse transcriptase inhibitor. Truvada: It is approved for all populations at risk through sexual exposure or injection drug use. Something to look out for before starting this medication is for pre-existing CKD. Do not give to patients who have an estimated glomerular filtration rate of less than 60 mL/min. (6) Descovy: This option is approved for men who have sex with men and transgender women but is not approved for individuals at risk through receptive vaginal sex. It has less impact on renal function and bone mineral density compared to Truvada. It can be used in moderately reduced kidney function (GFR between 30-60 mL/min). Truvada and Descovy are taken orally once a day.  After patients start taking these medications, when are they considered to be protected?  Nicole: With daily oral PrEP, guidelines differ with WHO and International Aids Society-USA stating it takes about 7 days, while CDC states 21 days to allow for adequate concentration in tissues (1). Adherence is critical for efficacy. Injectable HIV PrEP. In 2021, the FDA approved the first Injectable PrEP option Long-acting cabotegravir (CAB-LA)- known on the market as Apretude. Cabotegravir is an integrase strand transfer inhibitor administered as an intramuscular injection.Dosing consists of an initial injection, a second injection one month later, and then maintenance injections every two months (1). Another option is Lenacapavir (Yeztugo). The Yeztugo as a pre-exposure prophylaxis (PrEP) for HIV in Oct 2024. Yeztugo is the first and only FDA-approved HIV prevention treatment that requires just two injections per year, offering a long-acting option for people who weigh at least 35kg. It is given as 2 injections every 6 months. First dose is given with 2 tablets on Day 1 and Day 2, then every 6 months 2 injections on the same day. Clinical trials, including HPTN 083 and HPTN 084, demonstrated that injectable cabotegravir is superior to daily oral PrEP in preventing HIV infection. This advantage is largely due to improved adherence rather than differences in intrinsic drug potency. There have been no head-to-head comparisons between Yeztugo and Apretude, but they are both very effective. Apretude starts protecting 7 days after the first dose, and Yeztugo starts protecting 2 hours after Day 2 (if patient takes the oral loading dose) or 3-4 weeks if no oral load is taken. Injectable PrEP is particularly beneficial for patients who struggle with daily pill adherence, have trouble swallowing pills, prefer a discreet option, have difficulty storing their medication or have renal or bone disease that limits the use of tenofovir-based regimens like Truvada and Descovy (6). In one unpublished report by Medline, patients who received Apretude had an increase in bone mineral density compared to those who received Truvada (1). Tests prior to starting PrEP. Before initiating PrEP, patients must be confirmed to be HIV-negative. Baseline evaluation includes HIV testing with a fourth-generation antigen/antibody assay, HIV RNA testing if acute infection is suspected, renal function testing for oral PrEP, Hepatitis B screening, sexually transmitted infection screening, and pregnancy testing when appropriate. PrEP should not be started in individuals with known or suspected acute HIV infection. Monitoring for patients on HIV PrEP. Monitoring typically includes HIV testing every 2 to 3 months, STI screening every 3 to 6 months, renal function monitoring for those on oral PrEP (tenofovir- based), ongoing adherence and risk-reduction counseling. And for injectable PrEP, adherence to the injection schedule is essential, as delayed dosing may increase the risk of resistance if HIV infection occurs. HIV PrEP is not a prevention for other STIs. Screening for STIs and counseling about prevention is essential. Breakthrough HIV infections on PrEP are rare and most often associated with poor adherence or delayed diagnosis. Truvada is more studied in all populations and is considered safe during pregnancy and breastfeeding. There is less data regarding the injectable option in patients who are pregnant, may become pregnant, or whose primary risk factor is injection drug use (1). Injectable PrEP provides an important alternative for patients with chronic kidney disease and bone disease (1). Key Takeaway Pre-exposure prophylaxis is a safe, effective, and evidence-based strategy for HIV prevention. With both daily oral and long-acting injectable options available, PrEP can be individualized to meet patient needs. Normalizing PrEP discussions in clinical practice is essential to reducing new HIV infections and advancing public health goals.  Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!  References: Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel. The Journal of the American Medical Association. 2025. Gandhi RT, Landovitz RJ, Sax PE, et al. Long-Acting Lenacapavir Acts as an Effective Preexposure Prophylaxis in a Rectal SHIV Challenge Macaque Model. The Journal of Clinical Investigation. 2023. Bekerman E, Yant SR, VanderVeen L, et al. Pharmacokinetics and Safety of Once-Yearly Lenacapavir: A Phase 1, Open-Label Study. Lancet. 2025. Jogiraju V, Pawar P, Yager J, et al.

Colorectal cancer (cancer of the colon and rectum) is now the leading cause of cancer deaths in adults younger than 50. Rates have increased steadily over the past three decades, with the most dramatic rise seen in people in their 20s and 30s. In this episode we break down what that means for you and the people you love.  https://bit.ly/3OpPlk8Early colorectal cancer often has no symptoms at all, which is why screening guidelines were recently lowered to begin at age 45. When caught early, the five-year survival rate is 91%. When detected after it has spread, survival drops dramatically.We discuss:Why colorectal cancer is increasing in younger adultsThe subtle symptoms many people ignoreHow blood clots can complicate cancerLifestyle factors linked to riskWhy early-onset colorectal cancer tends to be more aggressiveHow to advocate for yourself if something feels “off”If you notice blood in your stool, persistent abdominal pain, changes in bowel habits, unexplained weight loss, or fatigue from anemia — do not dismiss it. Speak up. Get evaluated. Early detection can save your life.In this Episode:0:00 – Intro: Colorectal Cancer Cancer in Young Adults02:35 – Recipe: Yummy Ham & Pickle Rollups02:50 – “André Is An Idiot”: André Ricciardi's Terminal Creative Legacy 05:38 – Celebrity Case Studies: James Van Der Beek & Catherine O'Hara14:32 – Super Bowl Ad Alert: Multi-Cancer Tests & False Negatives16:54 – The Reality Check: Lifestyle Risks & Charlie's Personal Disclosure30:44 – Tracey Emin: Reclaiming Life After Radical Pelvic Surgery34:00 – Outro#ColorectalCancer #AndréRicciardi #TraceyEmin #JamesVanDerBeek #CatherineOHara #ColonCancer #CancerScreening #EarlyDetection #YoungAdultsHealth #CancerAwareness #PreventCancer #EveryoneDiesPodcast #KnowTheSigns #AdvocateForYourHealth Support the showGet show notes, images and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

Are mammograms truly protecting women — or is it time to rethink how we approach breast health? In this powerful and deeply nuanced conversation, Dr. Anna Cabeca sits down with former fellowship-trained breast surgeon turned integrative oncologist Dr. Jenn Simmons to unpack one of the most important questions in women's health today: Are mammograms safe — and are they enough? Together, they explore how conventional breast cancer screening became the standard, what the research actually says about radiation exposure and screening frequency, and why early detection is not the same as prevention. Dr. Simmons shares her personal turning point — from 17 years at the forefront of breast oncology to leaving conventional medicine and founding Real Health MD after her own health crisis. What she discovered changed everything: inflammation, toxicity, hormone disruption, and metabolic dysfunction matter far more than women are being told. This episode goes beyond mammograms. It dives into: • Radiation risks and over-screening • Alternative imaging options including thermography, ultrasound, and emerging technologies • Hormones and breast cancer — clearing the misinformation • Why anti-estrogen messaging can be harmful and incomplete • Bioidentical progesterone and protective mechanisms • Birth control pills and breast development risk • The power of metabolic health, fasting windows, detoxification, and terrain theory Most importantly, this conversation restores agency. You are not powerless when it comes to breast health. Knowledge is evolving. Screening is evolving. Hormone science is evolving. And you deserve the full picture. –––––––––––––––––– KEY TIMESTAMPS 00:00 Reimagining breast health and questioning the narrative 01:23 Introducing Dr. Jenn Simmons and her paradigm shift 09:47 From breast surgeon to integrative oncologist: her turning point 12:28 Functional medicine approach: "What caused the cancer?" 27:19 Mammography myths and reviewing the research 33:01 Radiation exposure: known carcinogen discussion 35:31 Biopsy concerns and imaging alternatives 42:07 Medical board pressures and guideline rigidity 53:04 "Anti-estrogen talk is misogynistic" 01:04:10 Birth control pills, teens, and breast cancer risk –––––––––––––––––– MEMORABLE QUOTES Dr. Jenn Simmons: "Radiation is a known carcinogen." "Any anti-estrogen talk is misogynistic." Dr. Anna Cabeca: "What caused your cancer to begin with?" "It takes more than hormones to fix our hormones." "There's always one next right step we can take to advocate for our health." –––––––––––––––––– CONNECT WITH DR. JENN SIMMONS Website: www.realhealthmd.comInstagram: @drjennsimmons YouTube: @dr.jennsimmons Book: The Smart Woman's Guide to Breast Cancer –––––––––––––––––– CONNECT WITH DR. ANNA CABECA Website: www.dranna.comInstagram: www.instagram.com/thegirlfrienddoctor YouTube: www.youtube.com/@thegirlfrienddoctor TikTok: www.tiktok.com/@drannacabeca Facebook: www.facebook.com/thegirlfrienddoctor –––––––––––––––––– If this episode spoke to you, share it with a girlfriend, your daughters, your mother — every woman deserves this conversation. You are seen. You are informed. You are empowered.

In this episode of One in Ten, host Teresa Huizar welcomes Dr. Brian Allen, professor in the Department of Pediatrics at Penn State, to discuss what motivates problematic sexual behavior (PSB) in children and youth and what the research shows. Allen explains his path into the field and why he conducted a meta-analysis—combining results across studies to create a much larger dataset (about 9,000 children) and examine the strength of associations across age, gender, and different risk factors.Time Stamps Time Topic 00:00 What Drives Problematic Sexual Behavior (PSB) in Kids? (Episode Intro) 01:15 Meet Dr. Brian Allen + How He Got Into PSB Research 02:54 Meta-Analysis 101: What It Is and Why It Matters for PSB 05:26 Beyond the Assumption: Is PSB Always Linked to Sexual Abuse? 07:24 Who's Affected? Gender & Age Patterns in the Data 08:41 Age Matters: Developmental Motivations, Curiosity & Online Exposure 14:01 Why Parents Struggle to Talk About Sex, Boundaries & Prevention 16:44 What the Meta-Analysis Found: PSB's Link to Sexual Abuse (and How to Ask) 19:00 Physical Abuse, Dysregulation & Coercion: A Surprising Strong Correlate 25:35 Screening & Mental Health: Externalizing vs Internalizing Problems 29:01 Big Research Gaps: Cross-Cultural Data, Developmental Pathways & Social Media 32:12 What's Next: New Assessment Tool, Longitudinal Studies & Treatment Trials 33:38 Key Takeaways for Clinicians: Treatable, Low Risk, Don't Go Punitive 36:22 Reframing These Kids + Resources, Training, and Closing 39:10 Final Thanks & Where to Learn More ResourcesProblematic Sexual Behavior Among Children: A Meta-Analysis of Demographic and Clinical Correlates | Research on Child and Adolescent Psychopathology | Springer Nature LinkSupport the showDid you like this episode? Please leave us a review on Apple Podcasts.

Oral Cancer Awareness and Adjunctive Screening DevicesBy Spring Hatfield, RDH, BSPHOriginal article published on Today's RDH: https://www.todaysrdh.com/oral-cancer-awareness-and-adjunctive-screening-devices/Need CE? Start earning CE credits today at https://rdh.tv/ce Get daily dental hygiene articles at https://www.todaysrdh.com Follow Today's RDH on Facebook: https://www.facebook.com/TodaysRDH/Follow Kara RDH on Facebook: https://www.facebook.com/DentalHygieneKaraRDH/Follow Kara RDH on Instagram: https://www.instagram.com/kara_rdh/

Pippa Hudson speaks to Melanie Verwoed about her new podcast, Grys en Gatvol, which she’s launched with Maritza Breitenbach to discuss menopause. They’re hosting a special film screening at the Labia Theatre called Prime Minister, about Jacinda Ardern. Lunch with Pippa Hudson is CapeTalk’s mid-afternoon show. This 2-hour respite from hard news encourages the audience to take the time to explore, taste, read, and reflect. The show - presented by former journalist, baker and water sports enthusiast Pippa Hudson - is unashamedly lifestyle driven. Popular features include a daily profile interview #OnTheCouch at 1:10 pm. Consumer issues are in the spotlight every Wednesday while the team also unpacks all things related to health, wealth & the environment. Thank you for listening to a podcast from Lunch with Pippa Hudson Listen live on Primedia+ weekdays between 13:00 and 15:00 (SA Time) to Lunch with Pippa Hudson broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/MdSlWEs or find all the catch-up podcasts here https://buff.ly/fDJWe69 Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Send Us Your Prayer Requests --------Thank you for listening! Your support of Joni and Friends helps make this show possible. Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org. Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

Postdoctoral researcher Wei Zhang discusses the article "Peripheral artery disease prevention: Saving limbs and lives." Wei explains how peripheral artery disease acts as a silent burden on the "life-highway" vessels of the body and why amputation rates are tragically rising by nearly 9 percent annually despite medical advancements. The conversation highlights the critical gap in early diagnosis caused by a "wait-to-see" mentality and exposes the deep socioeconomic disparities that leave marginalized communities at higher risk for limb loss. Wei outlines simple, proven prevention strategies that can save the health care system billions while preserving the fundamental human dignity of mobility and independence. Listen to learn how becoming the first guardian of your own vessel health can change the trajectory of your life. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Cev's here with details of this month's screening and how you can join in with the fun...All the links you think you'll need & more! HERE

David C. Roberson and Jason Goss break down the latest DCU news, casting updates, rumors, and clarifications from DC Studios.Bud Cort Dies at 77We begin by remembering Bud Cort, who voiced:Toyman on Superman: The Animated Series, Justice League Unlimited, and Static ShockJosiah Wormwood on Batman: The Animated SeriesSupergirl UpdatesSupergirl Meets Lobo TV SpotA new TV spot for Supergirl featuring Lobo has surfaced. https://www.youtube.com/watch?v=3TuUiYuaWCUBaby Krypto RevealedNew footage featuring Baby Krypto debuted during the Puppy Bowl and was later shared by James Gunn. https://youtu.be/VoqjnU_wGJM“We're Not Telling Woman of Tomorrow”Gunn clarified that the film is not a direct adaptation of Supergirl: Woman of Tomorrow, but rather inspired by its tone and structure.Supergirl Test ScreeningsReports suggest:A darker tone than SupermanA human trafficking storylineMore intense violenceStrong cinematographyA major role for Jason Momoa's LoboA redesigned, more menacing Krem of the Yellow HillsSources describe the film as balancing humor, darkness, and lightness.LanternsNew Lanterns Logo RevealedThe first official logo for Lanterns has been unveiled.ClayfaceProduction UpdateGunn confirms that director James Watkins is still working on the first cut of Clayface.The film remains on track for its 2026 release, though Warner Bros. has shifted the release date to October.Man of TomorrowBrainiac Casting ConfirmedLars Eidinger has been cast as Brainiac.Gunn shared that the character draws inspiration from multiple comic eras, including classic Otto Binder stories and more modern, darker interpretations.Casting UpdatesGunn confirmed:Smaller roles are currently being castThe rumored female role is NOT Wonder WomanMaxima RumorReports suggest Maxima may appear as a secondary antagonist before potentially shifting allegiances.Cinematographer ConfirmedSam McCurdy (Game of Thrones, Shōgun) joins as cinematographer.The Batman Part IICasting RumorsScarlett Johansson rumored as Gilda DentSebastian Stan rumored for Harvey DentReports suggest an older role may be Harvey Dent's fatherWe also discuss comic lore surrounding Harvey's abusive father and its potential influence.Batman: The Brave and the BoldChristina Hodson WritingTHR reports Christina Hodson is attached as screenwriter.Gunn defended her writing publicly, noting that screenplays often differ significantly from final films.No Actionable Script ReadyGunn says there is no “actionable script” yet and that DC is taking a measured development approach.Mister MiracleTom King confirms Mister Miracle is a DCU project with major implications and confirms Darkseid has been cast.DC Tea Batman & Wonder Woman Auditions Are FalseGunn states that rumors of Batman and Wonder Woman auditions are not true.He reaffirmed both characters' importance to the DCU.Wonder Woman Casting RumorDeuxmoi claims Adria Arjona is Gunn's top choice, though this remains unconfirmed.Dynamic Duo Not DCUThe animated Dynamic Duo project is not part of DCU canon.Grant Gustin Is Not the DCU FlashAfter hair-dye speculation online, Gunn shut down rumors that Gustin is the new Barry Allen.Blue Beetle 2?Director Angel Manuel Soto says he hopes to continue the story and would love to introduce Booster Gold, possibly even through animation.Creature CommandosSeason 2 AnimatingGunn confirmed that Creature Commandos Season 2 is animating, with more projects in development.Captain Atom RumorReports suggest Nathaniel Adam (Captain Atom) may appear in Season 2.“A Lot Close to Greenlight”When asked about upcoming DCU projects, Gunn stated that several are close to greenlight — and at least one already is.Zatanna & Lobo What-Could-Have-BeensEmerald Fennell revealed her darker, more psychological Zatanna script was likely “too far away from the genre” for DC Studios.Jason Fuchs reveals his Lobo plansSuperman Blu-ray SalesSuperman was the second top-selling Blu-ray of 2025, behind Wicked.

What does a pap smear test for, and what happens after an abnormal pap smear? In this episode of SHE MD, Mary Alice Haney interviews Dr. Thaïs Aliabadi to break down exactly what a pap smear is, how HPV affects cervical cancer risk, and what women need to know about abnormal results. A pap smear is a cervical cancer screening test that checks for precancerous and cancerous cells on the cervix. A pap smear does not test for ovarian cancer, uterine conditions, or all sexually transmitted infections. HPV testing is often performed at the same time because high risk HPV is the leading cause of cervical cancer.Can you have HPV with a normal Pap smear? What actually happens after an abnormal result? Dr. A answers these questions and more, explaining that while most HPV infections clear on their own within one to two years, monitoring and follow-up are key. The bottom line: cervical cancer is highly preventable with routine Pap and HPV screening—but annual well-woman visits are still essential for protecting your long-term health.Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.Sponsors:Premier Protein: Find your favorite flavor at PremierProtein.com or at Amazon, Walmart, and other major retailers.Midi Health - Ready to feel your best and write your second act script? Visit JoinMidi.com today to book your personalized, insurance-covered virtual visit. Bobbie: If you want to feed with confidence too, head to hibobbie.com — to the formula trusted by parents and loved by their babies — 700k and counting.Peloton - Let yourself run, lift, sculpt, push, and go. Explore the new Peloton Cross Training Tread+ at onepeloton.com What You'll Learn:What a pap smear actually tests for and what it does not screenHow HPV and pap smear testing work together to prevent cervical cancerWhat abnormal pap smear results like ASCUS, CIN1, CIN2, and CIN3 meanWhen a normal pap smear still requires follow up or colposcopyWhy regular pap smear screening makes cervical cancer almost entirely preventableKey Timestamps:00:00 Introduction02:00 What a pap smear tests for and what it does not check03:40 HPV explained: low risk vs high risk and why it's common05:15 Screening guidelines and why pap smear alone is not enough07:15 What types of results you can get back from a pap smear 17:20 When you need a colposcopy and what happens during the procedure22:15 Biopsy results and CIN staging explained34:00 Treatment options: cryotherapy, LEEP procedure, and cold knife cone35:40 Risks of aggressive LEEP and pregnancy considerations38:00 HPV dormancy and common misconceptions41:45 HPV vaccine recommendations and prevention43:00 Final takeaway: pap smear schedule vs well woman examKey Takeaways:A pap smear screens for cervical cancer and HPV, not STDs, ovarian cancer, or uterine conditionsHigh risk HPV, especially types 16 and 18, may require colposcopy even with a normal pap smearColposcopy and cervical biopsy confirm whether precancer cells are present and guide treatmentMost HPV infections clear naturally within one to two yearsCervical cancer is preventable with routine pap smear and HPV screening, but annual well woman exams remain essentialResources Mentioned in This Episode:

Send a textIn this episode of the PT Snacks Podcast, host Kasey delves into vertebra basilar insufficiency (VBI), a condition affecting the posterior cerebral circulation. Aimed at physical therapists and PT students, the episode explains the anatomy behind VBI, its symptoms, risk factors, and how to screen for it effectively. Kasey highlights the importance of understanding VBI's implications, potential triggers, and the role of physical therapists in identifying and managing this condition. The episode also touches on appropriate referral procedures and the limitations of traditional VBI tests. Listen in to enhance your knowledge and clinical skills regarding this critical topic.00:00 Introduction to PT Snacks Podcast00:15 Understanding Vertebra Basilar Insufficiency01:33 Anatomy Review: Blood Supply to the Brain05:17 Risk Factors for Vertebra Basilar Insufficiency06:16 Identifying VBI in the Clinic09:16 Diagnostic Tests and Safe Practices11:33 Referral Guidelines and Patient Communication13:52 Conclusion and Additional ResourcesSupport the showNeed CEUs? Unlock unlimited online courses, live webinars, and certification-prep programs with MedBridge. You'll get: Thousands of accredited, evidence-based courses across multiple specialties (PT, OT, AT, SLP) that count for state-license CEUs. Access anytime, from your office, phone, or home—perfect for busy clinicians. One annual subscription, no per-course fee. Special offers: Use code PTSNACKSPODCAST at checkout and save over $100. Students use code PTSNACKSPODCASTSTUDENT for a discounted annual plan. Studying for the NPTE? Check out PT Final Exam — they've helped thousands of students pass with confidence. Use code PTSnacks at checkout for a discount. Stay Connected! Follow so you never miss an episode. Send your questions via email to ptsnackspodcast@gmail.com Join the email list ...

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss diagnosis and treatment of MASH using a case-based approach with two master clinicians, one a hepatologist and the other a primary care physician. This special episode is supported by an independent educational grant from Boehringer Ingelheim. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Alina M. Allen, M.D. Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic. Susan Kuchera, M.D. - Program Director of the Jefferson Health Abington Family Medicine Residency Program, Clinical Associate Professor of Family and Community Medicine in the Sidney Kimmel Medical College of Thomas Jefferson University Selected references: Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care 2025;48(7):1057–1082  

In this week's episode, we examine the Community Wealth Bill now and Act and discuss how it might pave the way for better local procurement and build wealth locally as a slight antidote to Scotland's extractive economy. We discuss Kier Starmer and yet another U-turn as the UK Government continue to spin around. This time on English local elections. We look at the latest revelations about the criminal charges against former SNP CEO Peter Murrel, the detail of the allegations against him and the political fallout about the delay to his trial. We also discuss how this all reflects on the SNP as a party and the scorn that was heaped on folk who tried to flag up problems. We also discuss Alba, Alliance for Liberation Scotland, Jim Ratcliffe and much else besides.LinksFinland FilmGlasgow - 18th February - https://www.believeinscotland.org/shop/#!/Screening-of-Lesley-Riddochs-new-film-with-Q&A/p/807936451Musselburgh - 19th Februaryhttps://www.eventbrite.co.uk/e/lesley-riddoch-finland-the-happiest-country-that-almost-never-existed-tickets-1980183406875?aff=oddtdtcreatorCommunity Wealth Building Billhttps://spice-spotlight.scot/2025/11/11/an-introduction-to-the-community-wealth-building-scotland-bill/Band Back Together at the Òran Mór - Indpendence Gighttps://www.ticketsource.co.uk/independence-forum-scotland/were-putting-the-band-back-together-supporting-scottish-arts/e-rbjakzMorgan McSweeney's gang investigate journalists - National got there firsthttps://www.thenational.scot/newsletters/bulletin/1898/?nid=1898&ref=eb ★ Support this podcast ★

In this rich and reassuring conversation, Debbie sits down once again with Dr. Lexi Hill, a Maternal–Fetal Medicine specialist, to unpack what advanced maternal age really means today.   Together, they demystify the risks, clarify what's truly important in prenatal care, and offer practical guidance for parents, educators, and birth professionals alike. From essential screenings and advocacy tips to emotional wellness and preparing for birth, this episode blends evidence-based insight with compassion and clarity.   Whether you work with expectant families or are navigating pregnancy yourself, you'll walk away feeling informed, empowered, and ready to support safer, more confident journeys into parenthood.  About Dr. Lexi Hill  Dr. Lexi is a board-certified Maternal–Fetal Medicine specialist dedicated to supporting people through high-risk and medically complex pregnancies with clarity, compassion, and evidence-based care. With extensive experience in fetal imaging, prenatal diagnostics, and managing conditions such as advanced maternal age, hypertension, diabetes, and IVF-related risks, she is known for her ability to translate complex medical information into practical guidance for patients and professionals alike.  In addition to her clinical work, Dr. Lexi creates educational resources—including courses, videos, and advocacy tools—that empower families to ask informed questions and navigate pregnancy with confidence.  Listen & Learn:  Why "advanced maternal age" begins at 35, and why that number isn't magical but part of a gradual risk continuum.  That flexible, well-communicated birth plans are still absolutely possible, and valuable, for AMA pregnancies.   How to recognize red flags in prenatal care and advocate for clear communication and shared decision-making.  Which screenings and scans are essential during AMA pregnancies, especially the importance of a detailed anatomy ultrasound.  The key maternal risks that rise with age, including preeclampsia, gestational diabetes, and preterm birth.  The fetal risks associated with AMA, from chromosomal differences to growth concerns and stillbirth risk.  How AMA care typically includes early screening, mid-pregnancy anatomy scans, third trimester growth checks, and late-pregnancy monitoring pregnancy anatomy scans, third trimester growth checks, and late pregnancy monitoring.  Why combining IVF with AMA adds layers of risk, making early ultrasound, anatomy scans, and fetal echocardiograms even more important.  How a preconception consultation can help you understand risks, optimize health, and prepare for pregnancy with confidence.  Resources & Mentions:   Dr. Lexi's website (free resources for students and clients)  FREE Hypertensive High Risk Pregnancy Module Dr. Lexi's YouTube channel(opens in a new tab)  Related Products from InJoy:   Understanding Pregnancy Book + Web App Understanding Birth Book + Web App Related InJoy Podcasts   Expert Insights: Latest Updates on Gestational Diabetes with Lily Nichols, RDN 1 Kick, 2 Kicks, 7 Kicks More! A Stillbirth Prevention Program With Megan Aucutt of Healthy Birth Day, Inc Preeclampsia: What Every Educator Should Know with Adriane Burgess   

In lactation private practice, IBCLC's spend more time with families than most other healthcare providers.  This gives us more time to help identify issues and refer out for support.  In this episode Katie Oshita discusses what screenings can be beneficial to support dyads and what to do with that information.  Listen here for more.Podcast Host: Katie Oshita, RN, BSN, IBCLC has over 25 years of experience working in Maternal-Infant Medicine.  While Katie sees clients locally in western WA, Katie is also a telehealth lactation consultant believing that clients anywhere in the world deserve the best care possible for their needs.  Being an expert on TOTs, Katie helps families everywhere navigate breastfeeding struggles, especially when related to tongue tie or low supply.  Katie is also passionate about finding the root cause of symptoms, using Functional Medicine practices to help client not just survive, but truly thrive. Email katie@cuddlesandmilk.com or www.cuddlesandmilk.com  

On the KMOJ Morning Show, Chantel Sings speak with Dr. Andrew Bergersen about a community event offering free PSA testing through the Minnesota Urology Foundation. He explains how the simple blood test helps screen for prostate cancer, a disease that affects 1 in 8 men and disproportionately impacts Black men, who face significantly higher diagnosis and mortality rates. Dr. Bergersen outlines who should consider screening—men over 50 and Black men over 45—and what participants can expect, including results mailed within a few days. The conversation emphasizes the importance of early detection and accessible community health resources.

Tamie Gangloff is an MFT and National Business Development Representative for Healing at Hidden River. She is also an adjunct professor at West Chester University teaching Eating Disorder Psychology. Tamie completed her Master's in Clinical Psychology at Antioch University in Santa Barbara and has worked at all levels of care for eating disorders and substance abuse. She is an advocate with the Eating Disorders Coalition, Tamie is the Founding President of the Southwest Philly IAEDP chapter, and a former group leader for The National Alliance for Eating Disorders. She is the Medical Trauma Advisor for Root to Branch. Tamie is the author of 'Chronic Illness and Eating Disorders: Assessment, Clinical Skills and Lived Experiences' We discuss topics including: Chronic pain and suicide Screening questions to ask clients pertaining to chronic pain and eating disorders Invisible Disability Learning to ask for help Weight stigma with smaller bodies, larger bodies and "fit" bodies   SHOW NOTES: (Book) Chronic Illness and Eating Disorders instagram.com/authortamiegangloff _________________________________ If you have any questions regarding the topics discussed on this podcast, please reach out to Robyn directly via email: rlgrd@askaboutfood.com You can also connect with Robyn on social media by following her on Facebook, Instagram, Twitter, and LinkedIn. If you enjoyed this podcast, please leave a review on iTunes and subscribe. Visit Robyn's private practice website where you can subscribe to her free monthly insight newsletter, and receive your FREE GUIDE "Maximizing Your Time with Those Struggling with an Eating Disorder". Your Recovery Resource, Robyn's new online course for navigating your loved one's eating disorder, is available now! For more information on Robyn's book "The Eating Disorder Trap", please visit the Official "The Eating Disorder Trap" Website. "The Eating Disorder Trap" is also available for purchase on Amazon.

This week, Brent Leuthold joins me to review the new Gore Verbinski film, Good Luck, Have Fun, Don't Die in a feature review, then we review Sam Raimi's Send Help in this week's secondary review. We also discuss Super Bowl advertising, Catherine O'Hara, James Van Der Beek, and Bud Cort's passing, and more. Watch the Video Version of the Episode Here Timestamps Show Start - 00:28 Introducing Brent - 01:56 Screening in Indy - 18:11 News Before the Reviews - 21:55 Feature Review Good Luck, Have Fun, Don't Die (2026) - 38:39 Spoiler - 1:09:24 Secondary Review Send Help (2026) - 01:29:20 Spoiler - 02:00:00   Closing the Ep - 02:20:50 Patreon Clip - 02:23:01 Related Links Catherine O'Hara, 'Schitt's Creek' and 'Home Alone' Star, Dies at 71 James Van Der Beek, 'Dawson's Creek' Star, Dies at 48 Bud Cort, 'Harold and Maude' Star, Dies at 77  Follow the IFJA on Letterboxd Brent's Letterboxd Brent's Writing on Awake in the Dark  My 2026 Podcast and Writing Archive The Long Walk Book Reactions on Patreon The Gotham Project on Patreon Patreon Special - Mike Flanagan Remaking The Mist for Warner Bros. - Feb 10, 2026 Immediate Reaction - Mercy (2026) - Feb 10, 2026 Patreon Companion Episodes Collection  Indianapolis Theaters Alamo Drafthouse Indy Kan-Kan  Living Room Theaters Keystone Art  Flix Brewhouse  Ways to Support Us Support Us on Patreon for Exclusive Content Official OV Merch Buy Me A Coffee Obsessive Viewer Obsessive Viewer Presents: Anthology Obsessive Viewer Presents: Tower Junkies As Good As It Gets - Linktree Start Your Podcast with Libsyn Using Promo Code OBSESS  Follow Us on Social Media My Letterboxd | YouTube | Facebook | Twitter Instagram | Threads | Bluesky | TikTok | Tiny's Letterboxd  Mic Info Matt: ElectroVoice RE20 into RØDEcaster Pro II (Firmware: 1.6.8) Brent: Earthworks ICON Pro in Riverside FM  Episode Homepage: ObsessiveViewer.com/OV502  Next Week on the Podcast OV503 - Wuthering Heights (2026) & The Strangers: Chapter 3 (2026)

Get ready for a laugh-out-loud live episode! Hosts Chris and Stu discuss the top 5 needle drops in films with filmmakers David Gardner and Aaron Shrimpton!!https://www.eventbrite.co.uk/e/1981367598825?aff=oddtdtcreator - this is the link to Estuary Dreams Cinematic - Basildon VUE Cinema - Experimental and Narrative shorts February 26th - Screening 7pm. Pre-Social Event 5pm hit the link for more detailsRecording this episode was an absolute blast, and we hope you enjoy listening as much as we enjoyed creating it!Disclaimer: we talk utter drivel and do not listen if you are easily offendedFollow them on insta @estuarydreams @dvdgardner @aaronshrimptonSpecial Thanks to Our Sponsor:A big shoutout to our amazing sponsor, the Say What Podcast. Their support keeps us going strong, so be sure to check them out!Watch and Support Hardcore Listing!Want to watch this episode and help Hardcore Listing keep rolling? Head over to our Patreon page! By becoming a patron, you'll gain access to exclusive content, behind-the-scenes footage, and the chance to pick your very own Top 5 topics for future episodes!www.patreon.com/hardcorelistingStay Connected!Don't miss out on updates, extra content, and all things Hardcore Listing—follow us on social media:Twitter: @hardcorelistingInstagram: @hardcorelisting Hosted on Acast. See acast.com/privacy for more information.

Here's a quick recap of what happened in property management last week. Links and resources to each story are included below…00:00:20 — Housing for the 21st Century Act Passes (No Investor Ban Included) - House Republicans and Democrats just passed the Housing for the 21st Century Act. It's largely a “build more housing, faster” package — clearing federal review delays, reducing regulatory bottlenecks, and making it easier to develop missing middle and small multifamily housing. It also includes faster voucher lease-ups and some manufactured housing provisions. https://nypost.com/2026/02/11/real-estate/congress-advances-housing-bill-without-trumps-proposal-to-ban-investors/(One important note: the proposed ban on institutional investors buying single-family homes did not make it into the final bill. That piece was left out. So for now, there's no federal restriction coming on large-scale homebuyers. The supply-side reforms advanced. The investor restrictions didn't. Worth watching how that evolves.) 00:01:20 — HOA Manager Accused of Stealing $1M+An HOA manager has been accused of stealing more than $1 million in 2025, including at least $600,000 from one condo association. Allegations include forged checks and misdirected settlement funds. Wild story. But zoom out for a second — this is almost always a controls issue. One person had too much access and not enough oversight. Basic financial guardrails likely would have prevented this. Dual approval on disbursements, separation of reserve and operating accounts, bank statements going directly to board members. Processes are like plumbing — invisible when they work, a disaster when they don't. https://www.realtor.com/news/trends/hoa-manager-allegedly-scammed-people-out-of-1-million-over-4-years/00:02:08 — AppFolio Releases 2026 Property Management Benchmark Report! AppFolio just released its 2026 Property Management Benchmark Report, and a few things jumped out. https://www.appfolio.com/resources/library/benchmark-reportThe top two challenges operators reported were higher vacancy and rising operating costs. That's not surprising, but it's validating to see it confirmed at scale. In response, 86% of property managers say they're prioritizing resident experience — especially communication and reducing friction around move-ins.Fraud continues to go mainstream. More than half of respondents reported an increase in application fraud last year. That's huge. Screening and verification are becoming table stakes.And then there's AI. Forty-four percent of respondents say they're already using AI tools, and those users expect faster portfolio growth than non-users. Interesting correlation. If you're not experimenting yet, this might be your sign to start small and see what actually moves the needle.That's all the news I have for you this week. Have a good one.

Breast cancer screening fails most often where access is constrained: limited appointments, geographic gaps, dense breast tissue, and reliance on self-exams that depend entirely on human touch. Awareness alone doesn't close those gaps.In this episode, Dr. Karny Ilan, co-founder and CEO of Feminai, shares how physician-led product design, multidisciplinary collaboration, and rigorous clinical trials shaped a new model for breast screening access. The conversation explores a shift in how breast health is managed—from episodic screening to continuous, individualized monitoring. Rather than relying on infrequent appointments alone, it examines tools designed to track changes over time, at home, while remaining connected to clinical decision-making. Timestamps(00:11) Breast cancer risk shaped by genetics and lived exposure(08:37) Limits of traditional self-breast exams(09:09) Personal experience shaping breast health urgency(10:15) How at-home breast scanning detects change over time(12:42) Designing screening tools for dense breast tissue(17:03) Addressing breast size, shape, and post-surgical variation(18:31) Clinical trials revealing real-world usability gaps(20:13) Why ease of use affects screening reliability(29:29) Access gaps amplified by pandemic-era screening delays(38:09) Broad inclusion across age, risk, and body types Guest BioDr. Karny Ilan — Co-Founder and CEO, FeminaiDr. Karny Ilan is a general surgery resident at Sheba Medical Center and the co-founder and CEO of Feminai, a breast health company developing an AI-enabled disposable wearable patch and app for at-home breast exams. With a strong family history of breast cancer, she brings clinical experience and patient-centered design to building scalable screening tools that expand access and personalization.LinkedIn: https://www.linkedin.com/in/karny-ilan/Key PointsAccess constraints drive missed detection: Feminai targets screening gaps caused by geography, capacity, and avoidance.Physician-led design builds trust: Clinical credibility accelerated adoption with providers and investors.Dense breast tissue is a priority use case: The technology is designed to perform well where mammography often struggles.Personalized baselines change detection logic: Each scan is compared against the user's own prior data.Usability directly affects accuracy: Instructions, fit, and behavior shape downstream AI performance.Deep Dives1. At-home breast exams as infrastructureDesigned for frequent, low-friction useComplements rather than replaces imaging2. Patch and app workflowRisk stratification via medical questionnaireBluetooth-enabled scan uploads to secure cloudAI analysis with physician review3. Designing for every bodyStretch materials accommodate size variationDense tissue explicitly accounted forAdditional sizes planned as rollout expands4. Clinical trials beyond performance metricsUsability drove multiple design iterationsInstruction format affected adherenceShape changes required algorithm updates5. Personalized longitudinal trackingEach woman compared only to herselfChanges flagged based on deviation, not population averages6. Leadership and multidisciplinary teamsEngineers exposed to clinical sitesPatient stories shared to reinforce missionStability in leadership communication protected executionLinks & ReferencesBreast cancer screening beyond mammography (Mayo Clinic): https://www.mayoclinic.org/tests-procedures/mammogram/in-depth/breast-cancer/art-20047233Breast cancer screening recommendations (USPSTF): https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening

Did you hear that? Are we being watched? Join Zeth as he gets out his flashlight and explores the dark corners of film history, specifically the paranoia of the 1970s and how real life was reflected in the films America was watching. Those films include the first installment in Alan J. Pakula's so-called “paranoia trilogy,” 1971's ‘Klute' starring Jane Fonda and Donald Sutherland. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

As BMIs and weights increase across the US population, there have been increased calls for universal screening for existing DM at entrance to prenatal care, if under 20 weeks. Others, including the ACOG, prefer to screen early those with additional risk factors (like prior GDM HX, prior macrosomia, BMI >30, PCOS, first degree relative with diabetes, or age >40). In July 2024, the ACOG released its publication, “Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum”. In this guidance, it states, “At this time, there are insufficient data to support the best screening modality for pregestational diabetes in pregnancy, but consideration can be made to use the same diagnostic criteria as for the nonpregnant population (A1c value 6.5 or higher, or fasting plasma glucose value 126 mg/dL or higher, or 2-hour plasma glucose value 200 mg/dL or higher during a 75-g OGTT, or random plasma glucose value 200 mg/dL or higher in patients with classic hyperglycemia symptoms)”. However, a new proposed protocol has been published in AJOG for early screening for DM in pregnancy. This also describes the differences in diagnosis and care for Standard GDM diagnosed at 24-28 weeks, vs a diagnosis of pregestational DM diagnosis made prior to 20-weeks vs “early” GDM also diagnosed under 20 weeks of gestation. Listen in for details. 1. McLaren, Rodney et al.nA Proposed Classification of Diabetes Mellitus in PregnancyAmerican Journal of Obstetrics & Gynecology, Volume 0, Issue 0. Epub Feb 2, 2026; https://www.ajog.org/article/S0002-9378(26)00061-X/fulltext2. ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum; July 2024; https://journals.lww.com/greenjournal/abstract/2024/07000/acog_clinical_practice_update__screening_for.34.aspx3. Simmons, David et al. “Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.” The New England journal of medicine vol. 388,23 (2023): 2132-2144. doi:10.1056/NEJMoa2214956

In this episode of Mostly Superheroes, Logan Janis sits down with the real-life Batman of St. Louis to talk DC fandom, cosplay evolution, community impact, third spaces, mental health, and what it means to show up for your city. PLUS

Fed up of constantly striving for ultimate happiness? Fearne's dropping into your feed every week for some far more realistic chat about what's making her feel great, and what's making her feel rubbish.This is a safe space for all of us to get stuff off our chests. No judgement here! Want to join the chat? Send us a voicenote, DM, or comment on Instagram @happyplaceofficial!So, what's putting us in our happy place this week... and what things really are not?In this chat, Fearne covers:-Why changing your mind and opinions is a good thing-How to make cervical screenings less scary-Why trying new things is important even if you can't really be arsed-Boxing being a fun outlet for a bit of anger-Being ok with saying “I don't know”-Moving through extreme panic and anxiety-Coming to terms with it not being warm in the UK for A WHILE yet...plus Fearne gets an unexpected call from her son Rex!Not seen the cervical screening Instagram post? Here it is! Hosted on Acast. See acast.com/privacy for more information.

There are so many misconceptions about genetic screening. Unfortunately, this leads people to make uninformed decisions about testing, and it results in people just not doing enough of it. This is why I invited a fertility expert who has dedicated a lot of her research life to this very topic. I am so excited to have Dr. Nidhee Sachdev of OC Fertility join me on The Egg Whisperer Show to talk about genetic screening. We are talking about the many misconceptions about genetic testing, why this information is so important, and why more people should be testing pre-treatment. Read the full show notes on Dr. Aimee's website.You can find Dr. Nidhee Sachdev's site here. Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, March 9, 2026 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates

In episode 2004, Jack and Miles are joined by poet, former public defender, co-founder and Executive Director of Partners for Justice, and author of The Price of Mercy: Unfair Trials, a Violent System, and a Public Defender's Search for Justice in America, Emily Galvin-Almanza, to discuss… MAGA Thinks Disney Deep Cuts Justify Trump’s Racist AI Post, That’s Weird... There Was A DOJ Press Release Announcing Epstein’s Death Drafted The Day Before He Was Actually Killed? Epstein Isn’t Secretly Alive, According To Fortnite, Kamala Harris Is Back – This Time With More Cringey Memes! Department Of Defense Deploys Military To Theaters Playing “Melania” and more! Trump takes down racist AI video of Barack and Michelle Obama as monkeys Republicans rarely criticize Trump in his second term. A racist post briefly changed that Troll Who Created Trump’s Racist Obama Video Was Behind Another Viral Outrage Trump’s Dangerous Diversionary Device: Using Race to Erase Discourse 'I Didn’t Make a Mistake’: Trump Declines to Apologize for Racist Video of Obamas Trump accused of role in Epstein’s death in explosive email sent to FBI, documents reveal Epstein Files Reveal Prosecutors’ Announcement Dated Before His Death Jeffrey Epstein is not actually alive and playing 'Fortnite,' Epic Games says 'Jeffrey Epstein still alive?': Truth behind viral photo amid Epstein files release Epstein confirmation of death dated one day before he was found discovered in files Harris relaunches her old ‘Kamala HQ’ account as an online organizing project Kamala Harris Reboots KamalaHQ as Headquarters, a ‘Progressive’ Media Hub Aimed at Gen Z Voters Kamala Harris' first post since election day sparks 2028 presidential bid speculation CNN just described the Kamala headquarters_67 account as cringe. Chillingly Vain’ ‘Melania’ Documentary Absolutely Savaged by Critics Military Pressured to See ‘Melania’ Against Their Will Amazon MGM Goes on Offense as ‘Melania’ Gets Sacked at Super Bowl Box Office LISTEN: Vamonos by Elkin & NelsonSee omnystudio.com/listener for privacy information.

There has been a shift in cervical cancer screening from primary cytology based to HPV based. Even HPV screening has had its evolution from physician collected samples to patient self-collection, either in a clinical setting or at home with an approved collection system. In May 2025, the FDA cleared the first at-home self-collection kit for HPV screening, specifically the Teal Wand by Teal Health. Now, we are seeing the advent of POSSIBLY another avenue for cervical HPV testing- although it is a bit awkward: the use of menstrual blood as an HPV screening test. In this episode we will review a new cross-sectional, population-based study from China which compared testing menstrual blood for human papillomavirus during cervical cancer screening to clinician-collected cervical samples for human papillomavirus (HPV). This concept, and these results, are not new at all! And there are important limitations to consider at this time. Listen in for details.1. Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study. BMJ 2026; 392 doi: https://doi.org/10.1136/bmj-2025-084831 (Published 04 February 2026)BMJ 2026;392:e084831https://www.bmj.com/content/392/bmj-2025-0848312. Naseri S, Young S, Cruz G, Blumenthal PD. Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood. Obstet Gynecol. 2022 Sep 1;140(3):470-476. doi: 10.1097/AOG.0000000000004904. Epub 2022 Aug 3. PMID: 35926207; PMCID: PMC9377370.3. Fokom Domgue J, Chandra M, Oladoyin O, Desai M, Yu R, Shete S. Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening. JAMA Netw Open. 2026;9(2):e2558841. doi:10.1001/jamanetworkopen.2025.58841

This week’s Pulm PEEPs Pearls episode is all about spontaneous breathing trials (SBTs). SBTs are a standard part of the daily practice in the intensive care unit, but the exact methods vary across ICUs and institutions. Listen in to hear about the most common methods of SBTs, the physiology of each method, and what the evidence says. Contributors This episode was prepared with research by Pulm PEEPs Associate Editor George Doumat. Dustin Latimer, another Pulm PEEPs Associate Editor, assisted with audio and video editing. Key Learning Points What an SBT is really testing An SBT is a stress test for post-extubation work of breathing, not just a ventilator check. The goal is to balance sensitivity and specificity: Too hard → unnecessary failures and delayed extubation Too easy → false positives and higher risk of reintubation Common SBT modalities and how they compare T-piece No inspiratory support and no PEEP Highest work of breathing Most “physiologic” but often too strict Pressure support (PS) + PEEP (e.g., 5/5 or 8/5) Offsets ETT resistance and provides modest assistance Easier to pass than T-piece CPAP (0/5) No inspiratory help, but provides PEEP to counter ETT resistance Sits between PS and T-piece in difficulty Evidence favors pressure-supported SBTs for most patients Large meta-analysis (~6,000 patients, >40 RCTs): Pressure-supported SBTs increase successful extubation (~7% absolute benefit) No increase in reintubation rates Trials (e.g., FAST trial): Patients pass SBTs earlier Leads to earlier extubation and fewer ventilator-associated risks Bottom line: A 30-minute PS 5/5 SBT is evidence-based and appropriate for most stable ICU patients When a T-piece still makes sense T-piece SBTs are useful when: Cost of reintubation is high Difficult airway Prior failed extubation Pretest probability of success is low Prolonged or difficult weaning Tracheostomy vs extubation decisions Need to mimic physiology without positive pressure In LV dysfunction or pulmonary edema even small amounts PEEP may significantly improve physiology Some centers use a hybrid approach: PS SBT → short confirmatory T-piece before extubation CPAP as a middle ground Rationale: Allows full patient effort while compensating for ETT resistance Evidence: Fewer and smaller trials Possible modest improvement in extubation success No clear mortality or LOS benefit Reasonable option based on patient physiology, institutional protocols, and clinician comfort No single “perfect” SBT mode Across PS, T-piece, CPAP, and newer methods (e.g., high-flow via ETT) there are no consistent differences in mortality or length of stay What matters most: Daily protocolized screening Thoughtful bedside clinical judgment Matching SBT difficulty to patient-specific risk Institutional variation is normal—and acceptable Examples: PS 10/5 in postoperative surgical ICU patients PS 5/0 as an intermediate difficulty option Key question clinicians should ask: What does passing or failing this specific SBT tell me about this patient's likelihood of post-extubation success? Take-home pearls SBTs are stress tests of post-extubation physiology. PS 5/5 for 30 minutes is a strong default for most ICU patients. T-piece trials are valuable when false positives are costly or physiology demands it. CPAP is reasonable but supported by less robust data. Consistency, daily screening, and judgment matter more than the exact mode. References and Further Reading Burns KEA, Khan J, Phoophiboon V, Trivedi V, Gomez-Builes JC, Giammarioli B, Lewis K, Chaudhuri D, Desai K, Friedrich JO. Spontaneous Breathing Trial Techniques for Extubating Adults and Children Who Are Critically Ill: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Feb 5;7(2):e2356794. doi: 10.1001/jamanetworkopen.2023.56794. PMID: 38393729; PMCID: PMC10891471. Burns KEA, Sadeghirad B, Ghadimi M, Khan J, Phoophiboon V, Trivedi V, Gomez Builes C, Giammarioli B, Lewis K, Chaudhuri D, Desai K, Friedrich JO. Comparative effectiveness of alternative spontaneous breathing trial techniques: a systematic review and network meta-analysis of randomized trials. Crit Care. 2024 Jun 8;28(1):194. doi: 10.1186/s13054-024-04958-4. PMID: 38849936; PMCID: PMC11162018. Subirà C, Hernández G, Vázquez A, Rodríguez-García R, González-Castro A, García C, Rubio O, Ventura L, López A, de la Torre MC, Keough E, Arauzo V, Hermosa C, Sánchez C, Tizón A, Tenza E, Laborda C, Cabañes S, Lacueva V, Del Mar Fernández M, Arnau A, Fernández R. Effect of Pressure Support vs T-Piece Ventilation Strategies During Spontaneous Breathing Trials on Successful Extubation Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2019 Jun 11;321(22):2175-2182. doi: 10.1001/jama.2019.7234. Erratum in: JAMA. 2019 Aug 20;322(7):696. doi: 10.1001/jama.2019.11119. PMID: 31184740; PMCID: PMC6563557. Burns KEA, Wong J, Rizvi L, Lafreniere-Roula M, Thorpe K, Devlin JW, Cook DJ, Seely A, Dodek PM, Tanios M, Piraino T, Gouskos A, Kiedrowski KC, Kay P, Mitchell S, Merner GW, Mayette M, D’Aragon F, Lamontagne F, Rochwerg B, Turgeon A, Sia YT, Charbonney E, Aslanian P, Criner GJ, Hyzy RC, Beitler JR, Kassis EB, Kutsogiannis DJ, Meade MO, Liebler J, Iyer-Kumar S, Tsang J, Cirone R, Shanholtz C, Hill NS; Canadian Critical Care Trials Group. Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial. JAMA. 2024 Dec 3;332(21):1808-1821. doi: 10.1001/jama.2024.20631. PMID: 39382222; PMCID: PMC11581551. Mahul M, Jung B, Galia F, Molinari N, de Jong A, Coisel Y, Vaschetto R, Matecki S, Chanques G, Brochard L, Jaber S. Spontaneous breathing trial and post-extubation work of breathing in morbidly obese critically ill patients. Crit Care. 2016 Oct 27;20(1):346. doi: 10.1186/s13054-016-1457-4. PMID: 27784322; PMCID: PMC5081985. Yi LJ, Tian X, Chen M, Lei JM, Xiao N, Jiménez-Herrera MF. Comparative Efficacy and Safety of Four Different Spontaneous Breathing Trials for Weaning From Mechanical Ventilation: A Systematic Review and Network Meta-Analysis. Front Med (Lausanne). 2021 Nov 22;8:731196. doi: 10.3389/fmed.2021.731196. PMID: 34881255; PMCID: PMC8647911.​

AI in commercial real estate is usually framed around predictions and pricing.   In brief: Underwriting delays come from manual data extraction, not Excel. Institutional CRE teams automate the data layer, not the model. Parsing rent rolls and T12s is now a scale problem, not a staffing one. AI underwriting is being adopted first by lenders and servicers. Speed and consistency are emerging as underwriting risk controls. This Demo Day conversation with Parag Goswami, CEO of Clik.ai, focuses on something more fundamental: how underwriting actually gets done.   The core insight is simple.   The bottleneck in CRE underwriting is not Excel.   It is the manual, error-prone work of pulling data out of PDFs and forcing it into models. Clik.ai does not replace spreadsheets.   It automates everything before the spreadsheet matters by automating the tedious data input to your Excel model and automating it.   That is why its earliest adopters are institutional lenders, servicers, credit teams, and acquisitions pros.   Add to this automated Trepp comparable data and you have a high-value, early underwriting model to screen deals using your own Excel model.   Bottom line Clik.ai eliminates friction in the earliest stage of deal evaluation by automating the grunt work of data inputting giving you faster underwriting and a significant competitive edge.   ***   At GowerCrowd, we are aggressively researching AI tools you can actually use and that bring real, immediate value to your business. Contact us to learn more.   Subscribe to my newsletter and get access to this transformational intel before anyone else:  https://gowercrowd.com/subscribe Email: adam@gowercrowd.com Call: 213-761-1000

HEADLINE: Protecting US Data and Seeking Damages. GUEST: Brandon Weichert. SUMMARY: Weichert urges stricter tech transfer laws and stronger investment screening through CFIUS, arguing the US must hold China financially accountable for the COVID-19 pandemic's global damage. 1915

Attica! Attica! Join Zeth as he gets into emotional meltdowns, media circuses, and sympathetic criminals at the core of one of the greatest Hollywood films of all time, ‘Dog Day Afternoon' starring Al Pacino. And then stick around as we make a mixtape inspired by the film. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices